5‐methyl‐2‐carboxamidepyrrole‐based novel dual mPGES‐1/sEH inhibitors as promising anticancer candidates
Archiv der Pharmazie · 2025-01 · 358 (1)
DOI: 10.1002/ardp.202400708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 18.12.2024. Verfasst von Ester Colarusso und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, Fisciano, Italy. Hauptthemen laut MEDLINE: Prostaglandin-E Synthases, Antineoplastic Agents, Epoxide Hydrolases, Pyrroles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AIRC, Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).
Abstract (Originalsprache)
Inhibiting microsomal prostaglandin E 2 synthase‐1 (mPGES‐1), an inducible enzyme involved in prostaglandin E 2 (PGE 2 ) biosynthesis and tumor microenvironment (TME) homeostasis, is a valuable strategy for treating inflammation and cancer. In this work, 5‐methylcarboxamidepyrrole‐based molecules were designed and synthesized as new compounds targeting mPGES‐1. Remarkably, compounds 1f , 2b , 2c , and 2d were able to significantly reduce the activity of the isolated enzyme, showing IC 50 values in the low micromolar range. With the aim of further profiling the synthesized molecules, their ability to interfere with the activity of soluble epoxide hydrolase (sEH), whose inhibition blocks the loss of the anti‐inflammatory mediators epoxyeicosatrienoic acids (EETs or epoxyicosatrienoic acids), was investigated in silico and by employing specific biological assays. Among the set of tested compounds, 1f , 2b , 2c , and 2d emerged as mPGES‐1/sEH dual inhibitors. Moreover, given that overexpression of mPGES‐1 has been observed in many human tumors, we finally explored the biological effect of our compounds in an in vitro model of human colorectal cancer (CRC). The obtained outcomes pave the way for future investigation to optimize and further characterize anticancer pharmacological profile of the carboxamidepyrrole‐based molecules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Salerno, Fisciano, Italy.
- Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University, Jena, Germany.
- Department of Molecular Medicine and Medical Biotechnologies, School of Medicine and Surgery, University of Naples, Naples, Italy.
- BioChem Lab, Department of Pharmacy, School of Medicine and Surgery, University of Naples, Naples, Italy.
- Department of Biosciences and Territory, University of Molise, Pesche, Italy.
Förderung
- AIRC
- Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
Zitieren
APA
Colarusso, E., Lauro, G., Potenza, M., Galatello, P., Garigliota, M. L. D., Ferraro, M. G., Piccolo, M., Chini, M. G., Irace, C., Campiglia, P., Hoffstetter, R. K., Werz, O., Ramunno, A., & Bifulco, G. (2025). 5‐methyl‐2‐carboxamidepyrrole‐based novel dual mPGES‐1/sEH inhibitors as promising anticancer candidates. Archiv der Pharmazie, 358(1). https://doi.org/10.1002/ardp.202400708
Vancouver
Colarusso E, Lauro G, Potenza M, Galatello P, Garigliota MLD, Ferraro MG, et al. 5‐methyl‐2‐carboxamidepyrrole‐based novel dual mPGES‐1/sEH inhibitors as promising anticancer candidates. Archiv der Pharmazie. 2025;358(1). doi:10.1002/ardp.202400708
BibTeX
@article{Colarusso2025,
author = {Colarusso, Ester and Lauro, Gianluigi and Potenza, Marianna and Galatello, Paola and Garigliota, Maria Luisa d'Aulisio and Ferraro, Maria Grazia and Piccolo, Marialuisa and Chini, Maria Giovanna and Irace, Carlo and Campiglia, Pietro and Hoffstetter, Robert Klaus and Werz, Oliver and Ramunno, Anna and Bifulco, Giuseppe},
title = {5‐methyl‐2‐carboxamidepyrrole‐based novel dual mPGES‐1/sEH inhibitors as promising anticancer candidates},
journal = {Archiv der Pharmazie},
year = {2025},
volume = {358},
number = {1},
doi = {10.1002/ardp.202400708}
}
EUVIMED